Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

March 25, 2021

Effort seeks to enroll more Black patients in lung cancer trials

Researchers from Vanderbilt University Medical Center are part of a multi-institutional study that aims to improve participation in lung cancer clinical trials among Black patients from Southern states.

By Tom Wilemon
March 23, 2021

Prostate cancer microenvironment

Distinct cancer-associated fibroblasts in the prostate tumor microenvironment may influence tumor progression and could point to new therapeutic targets.

By Leigh MacMillan
March 18, 2021

EGFR Resisters/LUNGevity fund lung cancer research

Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.

By Tom Wilemon
March 9, 2021

Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening

A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.

By Tom Wilemon
March 9, 2021

Markers for breast cancer progression

Vanderbilt researchers clarify how a microRNA associated with triple-negative breast cancer survival inhibits cancer progression, suggesting new treatment strategies.

By Sarah E. Glass
Tyler Barrett, MD, MSCI, reviews an imaging scan in the VUAH Emergency Department, where a dedicated process ensures follow-up of suspicious images unrelated to a patient’s injuries. (photo by Susan Urmy)
February 4, 2021

Process ensures follow-up of incidental radiology findings

When people go to an emergency room after being injured, suspicious images may show up on their imaging scans that are unrelated to their injuries but may be indicative of cancer. A team at Vanderbilt University Medical Center recently established a better process for ensuring these patients receive follow-up diagnostic care, an initiative that is already receiving national recognition.

By Tom Wilemon
February 4, 2021

Gene network for leukemia factor

A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.
By Leigh MacMillan
January 21, 2021

WIN for blocking cancer growth

William Tansey and colleagues identified proteins that interact with the cancer drug target WDR5 and are important for cancer cell growth.
By Sarah E. Glass
January 21, 2021

Peal named Cancer Center associate operating officer

Karline Peal, MBA, BS, AS, RTT, was recently named associate operating officer of Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
January 8, 2021

Heather Jackson aims to improve lives, no matter where she serves

She was honored with the Five Pillar Leader Award at the latest virtual Leadership Assembly
By Jill Clendening
December 28, 2020

Pal named to cancer research national leadership posts

Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.
By Tom Wilemon
December 22, 2020

Arthritis drug may treat immunotherapy-related heart complication

By Tom Wilemon
December 17, 2020

Study reveals new strategy for reducing tumor growth, metastasis

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.
By Leigh MacMillan
1 … 12 13 14 15 16 … 58